Bluejay Diagnostics, Inc. - SIC # 3850 -

Ticker Exchange SIC # Website Latest Ticker
BJDX Nasdaq 3850 bluejaydx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Bluejay Diagnostics, Inc.

Bluejay Announces Abstract Accepted for Presentation at the 2025 Society of Academic Emergency Medicine (SAEM) Annual Meeting - Apr 15th, 2025 11:00 am
Bluejay Diagnostics Announces Entry into Warrant Inducement Transaction for Approximately $3.7 Million in Gross Proceeds - Apr 7th, 2025 9:21 pm
Bluejay Diagnostics Announces Reverse Stock Split - Nov 13th, 2024 10:10 pm
Bluejay Diagnostics Announces Closing of $8.75 Million Underwritten Public Offering - Jun 28th, 2024 3:32 pm
Top Midday Decliners - Jun 27th, 2024 6:00 pm
Bluejay Diagnostics Announces Pricing of $8.75 Million Underwritten Public Offering - Jun 27th, 2024 12:58 pm
SYMON-I Study of Symphony IL-6 Suggests Prediction of Mortality in Sepsis Patients - Jun 26th, 2024 12:00 pm
BJDX: 1Q:24 Financial Update - May 24th, 2024 9:00 am